Filter posts

Strong IP Protection is Critical Component of Trade Agreement

The next round of discussion on the Trans-Pacific Partnership (TPP) began yesterday in nearby Leesburg, …

Preview: AUTM U.S. Licensing Survey: FY2011

We’ve seen compelling evidence recently about the positive impact of university licensing activity. As we …

BIO Voices Agree: Intellectual Property Delivers

Over the last year, the U.S. Chamber of Commerce’s Global IP Center (GIPC) has met …

Novartis at India Supreme Court: Evergreening Myths and Patent Reality

Novartis will go before India’s Supreme Court on September 11, 2012 challenging the refusal by …

AMP v. Myriad: BIO Statement on Federal Circuit (Re)Decision

BIO released the following statement on the Federal Circuit’s decision in the AMP v. Myriad …

Technology Transfer Impact? Senator Bayh Informs on IPWatchdog

IPWatchdog published an article by former Senator Birch Bayh highlighting a BIO commissioned study showing …

USPTO Blogpost Brings Mayo Down to Earth

The United States Patent and Trademark Office Director David Kappos posted a blogpost called “Some …

Developments in the creation of a single EU Patent System stalled – Again.

By Catherine McLoughlin, specialist solicitor for Biotech and Pharmaceutical Companies, Pannone LLP After 40 years …

The U.S. Government’s Position in ACLU v. Myriad Genetics

Hans Sauer, BIO’s Deputy General Counsel for Intellectual Property, comments on  the Department of Justice’s brief …

Patent Evergreening in India: Response from the Other Side

Thank you Adriana for commenting on my article Patent “Ever-Greening”: Novartis Confronts Patent Myth in …